Concepedia

Alessia Gennarini

AG

Statistics

Publications

5

Citations

181

H-Index

5

Active since

2012

Affiliations

Mario Negri Institute for Pharmacological Research(Current)

Ospedale Papa Giovanni XXIII

Istituti di Ricovero e Cura a Carattere Scientifico

Luigi Sacco Hospital

University of Milan

Alessia Gennarini is an author at Mario Negri Institute for Pharmacological Research specializing in immunology, life sciences, and nephrology.

Publications per year

2012–2023

5

Publications

5

C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical Trial

Piero Ruggenenti, Erica Daina, Alessia Gennarini et al. · American Journal of Kidney Diseases · 2019 · 82 citations

, , +14

Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Primary Membranous Nephropathy: A Case Series

Manuel Alfredo Podestà, Matias Trillini, Valentina Portalupi et al. · American Journal of Kidney Diseases · 2023 · 37 citations · Full text

, , +17

Accelerating the Depletion of Circulating Anti-Phospholipase A<sub>2</sub> Receptor Antibodies in Patients with Severe Membranous Nephropathy: Preliminary Findings with Double Filtration Plasmapheresis and Ofatumumab

Manuel Alfredo Podestà, Alessia Gennarini, Valentina Portalupi et al. · ˜The œNephron journals/Nephron journals · 2019 · 34 citations

, , +17

Perioperative Minimal Induction Therapy: A Further Step toward More Effective Immunosuppression in Transplantation

Alessia Gennarini, Paolo Cravedi, Maddalena Marasà et al. · Journal of Transplantation · 2012 · 14 citations · Full text

, , +17

Anti–Phospholipase A2 Receptor 1 and Anti–Cysteine Rich Antibodies, Domain Recognition and Rituximab Efficacy in Membranous Nephropathy: A Prospective Cohort Study

Piero Ruggenenti, Linda Reinhard, Barbara Ruggiero et al. · American Journal of Kidney Diseases · 2023 · 14 citations · Full text

, , +15

1–5 of 5